0001144204-13-056135.txt : 20131021
0001144204-13-056135.hdr.sgml : 20131021
20131021171949
ACCESSION NUMBER: 0001144204-13-056135
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20131021
DATE AS OF CHANGE: 20131021
EFFECTIVENESS DATE: 20131021
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neurotrope, Inc.
CENTRAL INDEX KEY: 0001513856
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 463522381
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-204979
FILM NUMBER: 131162063
BUSINESS ADDRESS:
STREET 1: 10732 HAWK?S VISTA STREET
CITY: PLANTATION
STATE: FL
ZIP: 33324
BUSINESS PHONE: (945) 632-6630
MAIL ADDRESS:
STREET 1: 10732 HAWK?S VISTA STREET
CITY: PLANTATION
STATE: FL
ZIP: 33324
FORMER COMPANY:
FORMER CONFORMED NAME: BlueFlash Communications, Inc.
DATE OF NAME CHANGE: 20110223
D
1
primary_doc.xml
X0707
D
LIVE
0001513856
Neurotrope, Inc.
10732 HAWK'S VISTA STREET
PLANTATION
FL
FLORIDA
33324
(945) 632-6630
NEVADA
None
BlueFlash Communications, Inc.
Corporation
true
2011
James
New
10732 Hawk's Vista Street
Plantation
FL
FLORIDA
33324
Executive Officer
Director
John
Abeles
10732 Hawk's Vista Street
Plantation
FL
FLORIDA
33324
Director
William
Singer
10732 Hawk's Vista Street
Plantation
FL
FLORIDA
33324
Executive Officer
Director
Ralph
Bean
794 W. Shannon Road
Bridgeport
WV
WEST VIRGINIA
26630
Director
Robert
Weinstein
10732 Hawk's Vista Street
Plantation
FL
FLORIDA
33324
Executive Officer
Jay
M.
Haft
10732 Hawk's Vista Street
Plantation
FL
FLORIDA
33324
Director
Biotechnology
Decline to Disclose
- 06b
false
2013-10-04
false
true
true
0
EDI Financial, Inc.
15699
None
None
12221 MERIT DRIVE
SUITE 1020
DALLAS
TX
TEXAS
75251-2207
All States
false
1080000
1080000
0
false
13
108000
0
In addition to cash compensation of 10% from the amount sold, the broker-dealer also received 10-year warrants to purchase the number of shares of Series A Preferred Stock equal to 10% of the number of shares it sold to investors introduced by it.
0
false
Neurotrope, Inc.
/s/ James New
James New
President and Chief Executive Officer
2013-10-18